UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical infectious diseases, ISSN 1058-4838, 1/2015, Volume 60, Issue 1, pp. 143 - 153
HIV/AIDS | no | HIV-1 | emtricitabine | virological failure | antiretroviral therapy | lamivudine | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Anti-Retroviral Agents - therapeutic use | HIV Infections - epidemiology | HIV Infections - virology | Humans | Middle Aged | Netherlands - epidemiology | Male | Viral Load | Incidence | HIV-1 - isolation & purification | Treatment Failure | Adult | Female | HIV Infections - drug therapy | Antiretroviral Therapy, Highly Active - methods | Cohort Studies | Prescription drugs | Antiretroviral drugs | Regression analysis | Human immunodeficiency virus--HIV | Failure | Virology | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 01/2019, Volume 68, Issue 1, pp. 43 - 50
HIV/AIDS | virological failure | treatment dropout | antiretroviral therapy | China | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Humans | Middle Aged | Male | Secondary Prevention - methods | Young Adult | Anti-Retroviral Agents - administration & dosage | Treatment Failure | Adolescent | Aged, 80 and over | Adult | Female | HIV Infections - drug therapy | Aged | Antiretroviral Therapy, Highly Active - methods | Index Medicus | and Commentaries | HIV | AIDS
Journal Article
HIV medicine, ISSN 1464-2662, 2019, Volume 20, Issue 1, pp. 63 - 68
HIV‐1 | virological failure | HIV integrase inhibitors | combination antiretroviral therapy | dolutegravir monotherapy | HIV-1 | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | HIV Integrase Inhibitors - pharmacology | HIV-1 - drug effects | Heterocyclic Compounds, 3-Ring - pharmacology | HIV Infections - virology | Humans | Middle Aged | Male | CD4 Lymphocyte Count | HIV Infections - immunology | HIV-1 - physiology | Heterocyclic Compounds, 3-Ring - therapeutic use | Treatment Failure | HIV Integrase Inhibitors - therapeutic use | Adult | Female | HIV Infections - drug therapy | Maintenance Chemotherapy | Viral Load - drug effects | Therapy | Identification methods | Copy number | Lamivudine | Maintenance | Ribonucleic acid--RNA | Patients | Antiretroviral therapy | CD4 antigen | Antiretroviral agents | Human immunodeficiency virus--HIV | Peripheral blood mononuclear cells | Diagnosis | Deoxyribonucleic acid--DNA | Index Medicus | Short Communications | Short Communication
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 11/2013, Volume 57, Issue 10, pp. 1489 - 1496
HIV/AIDS | Antiretrovirals | HIV infections | HIV | RNA | Viremia | Health care industry | Viral load | Disease risks | Virology | Arts | Virological failure | Low-level viremia | Cohort study | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Immunopathology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | HIV Infections - virology | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Viremia - drug therapy | Viral Load | Incidence | Viremia - virology | Treatment Failure | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Cohort Studies | Measurement | Care and treatment | Research | HIV infection | Patient outcomes | Antiretroviral drugs | Comparative analysis | Ribonucleic acid--RNA | Human immunodeficiency virus--HIV | Risk assessment | Index Medicus
Journal Article
HIV medicine, ISSN 1464-2662, 01/2021, Volume 22, Issue 1, pp. 22 - 27
raltegravir | integrase inhibitors | virological failure | NRTI backbone | naïve | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Integrase | Emtricitabine | Backbone | RNA-directed DNA polymerase | Lamivudine | Risk | Thymidine | Ribonucleic acid--RNA | Drug resistance | Antiretroviral therapy | CD4 antigen | Tenofovir | Inhibitors | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Abacavir | Mutation | Index Medicus
Journal Article
Antiviral research, ISSN 0166-3542, 07/2020, Volume 179, pp. 104717 - 104717
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 2011, Volume 17, Issue 10, pp. 1966 - 1968
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Prognosis | HIV-1 - drug effects | HIV Infections - virology | Humans | Drug Resistance, Viral | HIV Reverse Transcriptase - genetics | HIV-1 - genetics | Antiretroviral Therapy, Highly Active | HIV Infections - diagnosis | Treatment Failure | Adult | HIV Infections - drug therapy | Mutation | Emigrants and Immigrants | Case studies | Antiviral agents | Diagnosis | Drug therapy | Health aspects | HIV infection | resource-limited setting | ART | early virological failure | HIV | antiretroviral therapy | HIV-1 subtype C | letter | Letters to the Editor | K65R | drug-resistant HIV-1 minority variants | retroviruses
Journal Article
HIV/AIDS (Auckland), ISSN 1179-1373, 11/2020, Volume 12, pp. 749 - 756
Antiviral agents | Highly active antiretroviral therapy | Adults | Patient compliance | Analysis | Variables | Ethics | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Data collection | Drug therapy | Public health | Antiretroviral therapy | CD4 antigen | Sociodemographics | highly active antiretroviral therapy | hiv/aids | virological failure | case-control study
Journal Article
HIV medicine, ISSN 1464-2662, 08/2020, Volume 21, Issue 7, pp. 457 - 462
viral load monitoring | South Africa | virological failure | HIV drug resistance | antiretroviral therapy | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Disease transmission | Telemedicine | Rural areas | Antiretroviral agents | Human immunodeficiency virus--HIV | Ribonucleic acid--RNA | Patients | Public health | Morbidity | Public sector | Antiretroviral therapy | Index Medicus | Short Communication
Journal Article
10.
Full Text
Very low level viraemia and risk of virological failure in treated HIV‐1‐infected patients
HIV medicine, ISSN 1464-2662, 03/2017, Volume 18, Issue 3, pp. 196 - 203
low‐level viraemia | cohort study | virological failure | HIV | residual viraemia | low-level viraemia | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Anti-Retroviral Agents - therapeutic use | Risk Assessment | Viremia | HIV Infections - virology | Humans | Middle Aged | Male | Risk | Viral Load | Incidence | Young Adult | HIV-1 - isolation & purification | Treatment Failure | Adolescent | Adult | Female | HIV Infections - drug therapy | Sustained Virologic Response | Cohort Studies | Highly active antiretroviral therapy | Antiviral agents | Care and treatment | HIV (Viruses) | Antiretroviral drugs | Health risks | Ribonucleic acid--RNA | Minority & ethnic groups | Patients | Low level | Antiretroviral therapy | CD4 antigen | Confidence intervals | Antiretroviral agents | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
HIV medicine, ISSN 1464-2662, 2017, Volume 18, Issue 3, pp. 171 - 180
virological failure | young people | perinatal HIV infection | Europe | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Anti-Retroviral Agents - therapeutic use | Humans | Drug Resistance, Viral | Child, Preschool | Infant | Male | Young Adult | Time Factors | Treatment Failure | Adolescent | Adult | Female | HIV Infections - drug therapy | Population Groups | Child | Cohort Studies | Highly active antiretroviral therapy | Protease inhibitors | Proteases | DNA polymerases | HIV patients | Youth | Teenagers | Comparative analysis | HIV (Viruses) | HIV infection | Epidemiology | Risk factors | Antiretroviral drugs | Young adults | RNA-directed DNA polymerase | Data processing | Infections | Risk analysis | Ribonucleic acid--RNA | Antiretroviral therapy | CD4 antigen | Confidence intervals | Perinatal infection | Developmental stages | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Adults | Children | Adolescents | Index Medicus | Original Research
Journal Article
HIV medicine, ISSN 1464-2662, 01/2020, Volume 21, Issue 1, pp. 21 - 29
resource‐limited setting | reversal | adherence counselling | virological failure | HIV | Antiretroviral drugs | Therapy | RNA-directed DNA polymerase | Antiretroviral agents | Human immunodeficiency virus--HIV | Counseling | Measurement methods | Mutation | Ribonucleic acid--RNA | Drug therapy | Antiretroviral therapy | CD4 antigen | Index Medicus | Original Research
Journal Article